Shares of Adeptus Health Inc (NYSE:ADPT) have earned a consensus recommendation of “Buy” from the ten ratings firms that are currently covering the company, Analyst Ratings.Net reports. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and six have issued a buy rating on the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $94.50.

Shares of Adeptus Health (NYSE:ADPT) traded down 8.54% during trading on Wednesday, reaching $47.25. 162,124 shares of the company were exchanged. Adeptus Health has a 1-year low of $30.12 and a 1-year high of $123.97. The firm has a 50-day moving average price of $52.73 and a 200-day moving average price of $79.29. The stock has a market capitalization of $673.64 million and a P/E ratio of 42.72.

ADPT has been the subject of several analyst reports. Zacks Investment Research raised shares of Adeptus Health from a “hold” rating to a “buy” rating and set a $97.00 price target for the company in a research note on Tuesday, September 29th. RBC Capital dropped their price target on shares of Adeptus Health from $114.00 to $92.00 and set an “outperform” rating for the company in a research note on Friday, October 23rd. KeyBanc dropped their price target on shares of Adeptus Health from $129.00 to $104.00 and set an “overweight” rating for the company in a research note on Friday, October 23rd. Piper Jaffray dropped their price target on shares of Adeptus Health from $130.00 to $109.00 in a research note on Friday, October 23rd. Finally, Dougherty & Co lowered their price objective on shares of Adeptus Health from $130.00 to $62.00 and set a “buy” rating for the company in a research report on Wednesday, November 18th.

An institutional investor recently raised its position in Adeptus Health stock. Shinko Asset Management Co. Ltd. raised its position in Adeptus Health Inc (NYSE:ADPT) by 16.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The hedge fund owned 38,061 shares of the company’s stock after buying an additional 5,374 shares during the period. Shinko Asset Management Co. Ltd. owned approximately 0.27% of Adeptus Health worth $2,075,000 at the end of the most recent quarter.

Adeptus Health Inc. is a holding company. The Company owns and operates First Choice Emergency Rooms, a network of independent freestanding emergency rooms in the United States. The Company provides emergency care through its freestanding emergency rooms. The Company provides patients with access to Board-certified physicians and emergency trained registered nurses and treatments on‑site. The Company’s facilities are equipped with radiology suite, including computerized tomography (NYSE:ADPT) scanners, digital x-ray and ultrasound, as well as onsite laboratories. As of December 31, 2014, the Company had 55 facilities. The Company’s facilities are located in the Houston, Dallas/Fort Worth, San Antonio and Austin, Texas markets; Colorado Springs and Denver, Colorado, and Phoenix, Arizona.

12 Month Chart for NYSE:ADPT

Frustrated with your broker? Are you tired of paying high fees? Do you feel like you are getting ripped off by your stock broker? It's time for a change. Find out which brokerage is best for your personal trading style at the InvestorPlace Broker Center. Compare brokers at a glance in the InvestorPlace Broker Center (Click Here).

Receive News & Ratings for Adeptus Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adeptus Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.